Dr. Bharat Bhushan received an M.S. in mechanical engineering from the Massachusetts Institute of Technology in 1971, an M.S. in mechanics and a Ph.D. in mechanical engineering from the University of Colorado at Boulder in 1973 and 1976, respectively, an MBA from Rensselaer Polytechnic Institute at Troy, NY in 1980, Doctor Technicae from the University of Trondheim at Trondheim, Norway in 1990, a Doctor of Technical Sciences from the Warsaw University of Technology at Warsaw, Poland in 1996, Honorary Doctor of Science from the National Academy of Sciences, Gomel, Belarus in 2000, University of Kragujevac, Serbia in 2011, and University of Tyumen, Russia in 2019. He is a registered professional engineer. He is an Academy Professor (San Jose, CA), and has served as an Ohio Eminent Scholar and The Howard D. Winbigler Professor in the College of Engineering, Director of the Nanoprobe Laboratory for Bio- & Nanotechnology and Biomimetics (NLB2), and affiliated faculty in John Glenn College of Public Affairs at the Ohio State University, Columbus, Ohio. In 2013-14, he served as ASME/AAAS Science & Technology Policy Fellow, House Committee on Science, Space & Technology, United States Congress, Washington, DC. He has served as Expert Investigator on IP related issues in the U.S. and International Courts.

As the Founder and Principal at Pharmaceutical Consulting LLC, Dr. Das coordinates the interface between client needs and external services/capabilities to facilitate strategic positioning for optimal product development and global registration. Services provided to clients in response to specific requests include regulatory input, risk analysis, cost estimates, process design, and combination (drug/device) product development for both small and macromolecules. He has been involved in combination biopharmaceutical product development for more than 30 years related to parenteral (pulmonary, transdermal, intravenous and implanted) and oral drug delivery therapeutic strategies. Dr. Das has authored and coordinated the filing of 29 IND’s for both small and macromolecules and assisted with the successful submission and registration of 3 CTD/NDA’s (for Dry Powder Inhaled Insulin, “Exubera®”, approved by the FDA and EMA in Jan 2006; Thermal Aerosol Vapor Generated Staccato Loxapine, “Adasuve®” approved by the FDA and EMA Dec 2012 and Dry Powder Inhaled Tobramycin, “Tobi Podhaler®” approved by the FDA and EMA March 2013). These efforts were directed to both single drug and combination products used for the treatment of infectious, allergic, genetic and neurological diseases. He is an Inventor on 8 issued Patents covering thiocationic lipids for gene delivery, a taste masked Ibuprofen suckable tablet and spray dried formulations for nasal and inhaled drug delivery. Dr. Das earned his Ph.D. degree in Chemical Engineering studying the effects of inhaled inorganic dusts and their role in the etiology of silicosis at a joint program between West Virginia University and the National Institutes for Occupational Safety and Health and an MBA (Strategy) from the University of California at Irvine. He also earned an MS degree in Chemical Engineering from Carnegie Mellon University supported by a Mellon Fellowship and a BS degree in Chemical Engineering from the University of New Hampshire supported by Scholarships from the International Students Office and a Fellowship from the Winchester R. Wood Memorial Foundation.

Physician, immunologist and molecular biologist with extensive global leadership experience in clinical research and development, translational medicine, business development and medical affairs. Led the clinical strategy for multiple CBER/CDER meetings and submissions (pre-IND through NDA) for FDA, EMA and China's NMDA. Executive contributor to multiple funding rounds in public/private financings, including IPOs, mergers and acquisitions.

Dr. Mahadevan Seetharaman is a Duke Integrative Healthcare Leader and Founder of Ayurveda Living. As an Ayurveda Diet & Nutrition Consultant and Yoga Teacher, he provides up-to-data Ayurveda/Yoga related health and wellness information, directory, research, news, and reviews. Dr. Mahadevan serves on the Boards of the Global Council for Ayurveda Research (GCAR), American Association of Ayurvedic Professionals (AAAP), the American Academy of Yoga and Meditation (AAYM),and co-founded the Texas Ayurveda Professionals Association (TAPAS). He was previously the CEO and Managing Director at one of the largest integrative research university hospitals in India – the Institute of Ayurveda & Integrative Medicine (I-AIM). During this time, he served as Professor & Dean, School of Health Sciences. Since then, he has helped set up an Integrative Healthcare Centre as the COO of Isha Arogya Research Foundation. He currently serves as a Visiting Professor at the Transdisciplinary University (TDU) and volunteers at the Hindu University of America (HUA).

Petros A Ghazaryan is a Professor in Department of Pharm-chemistry at Yerevan State University since 1998.In 1969 he graduated from Yerevan State University with major in biochemistry. The most important outcomes of the scientific results: He has developed and proposed methods for diagnosis and differential diagnosis of diseases, for hemoblastosis prognosis, diagnosis and therapy methods. 'Petamcin-A' is a medicine created by him which is introduced in practical medicine.His Research Interest are proposed methods for diagnosis and differential diagnosis of diseases, for hemoblastosis prognosis, diagnosis and therapy methods.

Computational biologist specializing in next-generation sequencing data analysis, genome annotation improvement, and protein modeling. Diverse experience across phases of drug development and therapeutic areas with expertise in infectious disease, immunology, astrobiology, and oncology. Graduated from Rutgers, State University of New Jersey, and Michigan State University.

Prof.dr.ir. Rene H. Wijffels is professor in Bioprocess Engineering at Wageningen University in the Netherlands. Research is focused on production of biomass, specific biomass ingredients and enzymatic conversions at high efficiencies and high volumetric productivities. For an optimal biomass productivity an integrated approach is used in which the production system (the bioreactor) is improved, the molecular metabolism is controlled (metabolic flux) and the compounds are isolated (biorefinery): www.bpe.wur.nl. We have an extensive microalgae research program in collaboration with industry (www.algae.wur.nl). Rene is scientific director of the pilot plant facility AlgaePARC (www.AlgaePARC.com) and director of the Centre for Biobased Economy (www.CBBE.nl). The Centre for Biobased Economy develops biobased education and applied research programs.

Immunologist,Certified, Drug Safety Officer,Pharmacovigilance and Clinical Trials Specialist. Currently working at Seramun Diagnostica Biotechnology Company in the Dept.of Research and Development as a Research & Development Scientist in the field of Immunoassay.Completed PhD from Charite’-University of Medicine Berlin, Center for Internal Medicine and Dermatology, Internal Medicine Dept. of Rheumatology and Clinical Immunology; German Rheumatology Research Center Berlin; Institute for Immunology, Center for Infection Medicine of Freie University Berlin. Ambassador of Brain City Berlin for Science and Technology. Diaspora Expert for Developing Countries in relation to health, education, research and consultation. Co-advisor and lecturer for Master and PhD students & lecturer of undergraduate students in different Ethiopian Universities. Ambassador of Tedda Health Science College in Gonder/ Ethiopia. Board Member of Ethiopian Institute of Textile and Fashion Technology EiTEX & Biorefinery Research Center (BRRC of EiTEX) in Bahir Dar University-Ethiopia, Board Member & Co-Founder and General Secretary of International Verein für Gesundheitsförderung in Äthiopien (IVGFÄ) at Germany. Vice-President of Bridge Ethiopia Network for Science and Technology (BE-NeST) in Germany. Auditor of German Society for Lupus Research Society/ Deutsche Gesellschaft für Lupus Forschung (DGLF) e,V.in Berlin-Germany.

Dr. Zengqiang Zhang is Full Professor for Environmental Science and Technology at the Northwest A&F University, China. Prof. Zhang has gained national and international recognition for his applied research work in organic waste treatment and soil heavy metal pollution remediation. His main research is on organic waste composting and land application, soils and sediments pollution by potentially toxic elements and remediation. He also has a certain expertise in remediation of contaminated soils using various soil amendments and environmental wastes, water treatments and pollution control, solid and hazardous waste management, and environmental risk assessment.

Dr. Kajal Gupta is an Assistant Professor in the Department of Surgery at Rush University Medical Center's in Divisions of General Surgery and Pediatric Surgery. Her group focuses on applying immuno-oncology research with the goal of developing novel combination immunotherapies and new molecular and cellular immunity agents for the immune-based treatment and prevention of human malignancies. In order to develop and translate novel laboratory research findings into more effective immunotherapies for cancer treatment and prevention, it is important to: (a) define the fundamental regulatory mechanisms that support anti-tumor immunity or facilitate tumor immune evasion; (b) dissect the transcriptional and cellular mechanism of the tumor immune microenvironment to discover new immunotherapeutic targets and predictive biomarkers.

Dr. Barakat received his PhD in biophysics from the University of Alberta in 2012 followed by a postdoctoral fellowship in the lab of the Nobel Laureate, Professor Michael Houghton, for two years. During his career, Dr. Barakat received numerous awards including the CIHR and AIHS postdoctoral fellowships, the prestigious UofA dissertation award, the ACRI Studentship and many distinction awards throughout his undergraduate and graduate studies. Dr. Barakat is also the editor of a number of journals. Dr. Barakat's lab is supported by different funding agencies including the Alberta Cancer Foundation, Li Ka Shing Applied Virology Institute, Natural Sciences and Engineering Research Council (NSERC), Li Ka Shing Institute of Virology and IC-IMPACTS Centres of Excellence. Dr. Barakat is also the CEO & co-founder of HEKA Therapeutics Inc. and co-founder of ACHLYS; two spinoff companies devoted to drug discovery of immune checkpoints small molecule inhibitors and predicting off-target toxicity of new compounds in drug discovery.

Dr. Janina Beilner, senior vice president education services & workforce solutions, customer services for Siemens Healthineers, is responsible for internal customer service education, external customer education and workforce solutions. Janina leads the vision and strategy for the customer service education and workforce position with over 15 years of professional experience in leading health care businesses, as well being a medical doctor. Janina is also an appointed lecturer at FAU Erlangen-Nürnberg, conducting a seminar “Leading by Learning,” affiliated to the Technical University under the chair of artificial intelligence and biomedical engineering/machine learning and data analytics.

Professor Vladimir G. Chigrinov is Professor of Hong Kong University of Science and Technology since 1999. He is an Expert in Flat Panel Technology in Russia, recognized by the World Technology Evaluation Centre, 1994, and SID Fellow since 2008. He is an author of 6 books, 31 reviews and book chapters, about 317 journal papers, more than 668 Conference presentations, and 121 patents and patent applications including 36 US patents in the field of liquid crystals since 1974. He got Excellent Research Award of HKUST School of Engineering in 2012. He obtained Gold Medal and The Best Award in the Invention & Innovation Awards 2014 held at the Malaysia Technology Expo (MTE) 2014, which was hosted in Kuala Lumpur, Malaysia, on 20-22 Feb 2014. He is a Member of EU Academy of Sciences (EUAS) since July 2017. He got A Slottow Owaki Prize of SID in 2018 . He is 2019 Distinguished Fellow of IETI (International Engineering and Technology Institute)

Dr. Aviv Asher is the head of animal science unit in MIGAL research institute and the northern R & D. Dr Asher is a physiologist/nutritionist and Chrono- biologist of ruminants and many of his scientific research is dealing with factors that effects feed and production efficiency including the correlation between feed efficiency and animal welfare of livestock. During the last 8 years one of the main issues that Dr. Asher is investigating is the influence of modern artificial light (mainly LED illumination) on the production, feed efficiency, welfare of dairy and beef cattle and on sheep and goats. Dr. Asher also lead scientific projects regarding to Precision livestock farming technologies for managing livestock in pasture with holistic grazing management, which offers the potential to make farming more sustainable and efficient. Another research topics that Dr. Asher is promoting is investigating new sustainable forage crops using high quality and advanced Nutritional experiments that examine the effect of the crops on feed efficiency and GHG emission.

Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduated magna cum laude with a BS in Neuroscience and distinction in honors from Baylor University. He completed his MD/PhD, Master’s in Clinical and Translational Research, and the Global Health Track at West Virginia University School of Medicine. His research focus was on traumatic brain injury, neurosurgical simulation, and stroke. At West Virginia University, he also served as a health coach for the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company Wright-Wold Scientific, the pharmaceutical company CTE cure, and was a science advocate on Capitol Hill through the Washington Fellow’s program.

Gang Fang is an Assistant Professor of Biology, NYU Shanghai; Global Network Assistant Professor, NYU. He is also affiliate assistant professor in the Department of Biology and Center for Genomics and Systems Biology at NYU's campus in New York City. Prior to joining NYU Shanghai, he was an associate research scientist at Yale University. He holds a PhD from Institute Pasteur, France, and BS and MS degrees from Peking University, China.

Dr Camillo Porcaro is a computational neuroscientist with a core interest in the development of analytical methods for extracting information from non-invasive measures of brain activity. His research focuses on identifying functional brain sources from data obtained through neuroimaging techniques. In 2008, he defended his PhD dissertation with honors in 'Functional Neuroimaging: from cells to systems' at the Institute for Advanced Biomedical Technologies (ITAB), University of Chieti, Italy. In the same year, Dr Porcaro became a Postdoctoral Fellow at the University of Birmingham, School of Psychology, using simultaneous EEG/fMRI. In 2011, he joined the Institute of Neuroscience, Newcastle University, after being awarded a highly competitive independent research position.

Umut Kökbaş works in the Department of Medical Biochemistry at Nevşehir Hacı Bektaş Veli University, Department of Basic Medical Sciences. He has researches in the field of biotechnological biochemistry.

Xinshao Wang is a senior researcher of Zenith Ai. He was a postdoctoral researcher at the Department of Engineering Science, University of Oxford after finishing his PhD at the Queens University of Belfast, UK. Xinshao Wang is working on core deep learning techniques with applications to visual recognition, disease prediction based on electronic health records, and protein engineering. Concretely, he has been working on the following topics: (1) Deep metric learning: to learn discriminative and robust representations for downstream tasks, e.g., object retrieval and clustering; (2) Robust deep learning: robust learning and inference under adverse conditions, e.g., noisy labels, missing labels (semi supervised learning), out-of-distribution training examples, sample imbalance, etc; (3) Computer vision: video/set-based person re-identification; image/video classification/retrieval/clustering; (4) AI healthcare: electrocardiogram classification; (5) ML-assisted gene and protein engineering.

Huixun “Zoe” Du is a fourth-year Ph.D. student at the Buck Institute of Research on Aging, where she works in the lab of Dr. Daniel Winer. Her research focuses on investigating the modulation of mechanical signals on cell inflammatory phenotypes using Next Generation Sequencing tools. With a keen interest in the intersection of aging and immunology, Zoe is passionate about contributing to the active effort to tackle age-related immune decline in the biotech industry. Through her research and aspirations, she aims to make a positive impact on human health and well-being.

I am a biologist, graduated from the Federal University of Viçosa, master and doctor in Agricultural Microbiology from the same university. Currently, I work as a collaborating researcher at the Laboratory of Biotechnology and Biodiversity for the Environment, of the Department of Microbiology at UFV, in the development of a biological product for the control of phytopathogenic fungi. I have extensive experience in research, mainly in the areas of microbiology and biotechnology. I have developed projects involving the bioremediation of soils contaminated with petroleum, the bioprospection of bacterial metabolites of biotechnological interest, the genetic improvement of a bacterial strain and the optimization of bioprocesses. Throughout the execution of these projects, I acquired vast knowledge in routine techniques of microbiology laboratories, molecular biology techniques and equipment handling. In my career as a researcher, I worked on the elaboration and improvement of protocols, seeking to avoid waste and reduce the generation of waste; I improved my capacity for experimental planning, conducting experiments and scientific writing. Additionally, I coordinated the laboratory, contributing to team management and organization of the work environment, and providing support to colleagues in the development of their research. I am a committed professional, driven by challenges and organized. Understanding natural processes, especially those that occur in the microbial world, and applying them to build a more sustainable world is what motivates me professionally.

Akshay Agarwal is a Research Engineer in AI and Cognitive Solutions group at IBM’s Almaden Research Center. He is the ML lead for the Functional Genomics Platform and has experience in applying ML and AI techniques to different problem areas, such as biology and social networks. His current interests are annotation of hypothetical proteins, epitope analysis in SARS-CoV-2 and predicting hypervirulence in Klebsiella. He graduated with a Masters in Computer Science from Georgia Tech with a specialization in Interactive Intelligence.

Researcher at the Biotechnology Division of Cristália Laboratory. He works in the area of ​​development of biological products and with the genetic heritage of Brazilian biodiversity. He is a member of the Internal Biosafety Commission (CIBio). Master in Pharmacology, licensed and bachelor in Biology by Unesp/Botucatu. Developed activities in the area of ​​Medicinal Plants and Molecular Biology. He holds an MBA in Strategic Management of New Businesses from Anhanguera/Uniderp (TCC: The Biological Medicines Market: Opportunities and Challenges for Brazil). Green Belt Lean Six-Sigma certified by Escola EDTI.

Dr Dibyajyoti Banerjee, MD is currently working as Professor, Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, PGIMER, Chandigarh, India. He is interested in developing novel concepts for drug development and his several concepts are published and many researchers are working with it. His focus in drug development is diabetes and tuberculosis. Apart from drug development he is interested in developing point of care testing tools. In this area also he has developed several tools which are in current use.